Degenerative brain diseases and white matter injury

White Matter Injury in Stroke and CNS Disease

Volumn , Issue , 2014, Pages 281-319

  Bartzokis, George ^a,b   Lu, Po H ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84912526431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-9123-1_14     Document Type: Chapter

References (259)

1. Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, Filippi M (2011) White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 258(3): 853-863. doi:10.1148/radiol. 10101284
2. Alba-Ferrara LM, de Erausquin GA (2013) What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Front Integr Neurosci 7:9. doi:10.3389/fnint.2013.00009
3. Als H, Duffy FH, McAnulty GB, Rivkin MJ, Vajapeyam S, Mulkern RV, Warfield SK, Huppi PS, Butler SC, Conneman N, Fischer C, Eichenwald EC (2004) Early experience alters brain function and structure. Pediatrics 113(4):846-857
4. Ames A 3rd (2000) CNS energy metabolism as related to function. Brain Res Brain Res Rev 34(1-2):42-68
5. Arnold AC, Gallagher PE, Diz DI (2013) Brain renin-angiotensin system in the nexus of hypertension and aging. Hypertens Res 36(1):5-13
6. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA (2011) Microinfarct pathology, dementia, and cognitive systems. Stroke 42(3):722-727. doi:10.1161/strokeaha.110.595082
7. Ashford JW (2004) APOE genotype effects on alzheimer's disease onset and epidemiology. J Mol Neurosci 23(3):157-166
8. Azim K, Butt AM (2011) GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59(4):540-553
9. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJ, Altmann F, Lubec G, Kotter MR (2009) Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132(Pt 2):465-481
10. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10(9):819-828
11. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA (2012) Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69(5):493-498
12. Barton RA, Harvey PH (2000) Mosaic evolution of brain structure in mammals. Nature 405(6790): 1055-1058
13. Bartzokis G (2002) Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27(4):672-683. doi:10.1016/S0893-133X(02)00364-0
14. Bartzokis G (2004a) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5-18. doi:10.1016/j.neurobiolaging. 2003.03.001, Author reply 25:49-62
15. Bartzokis G (2004b) Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatrie disorders. Neurobiol Aging 25(1):49-62. doi:10.1016/j.neurobiolaging.2003.08.001
16. Bartzokis G (2005) Brain myelination in prevalent neuropsychiatric developmental disorders: Primary and comorbid addiction. Adolesc Psychiatry 29:55-96
17. Bartzokis G (2011a) Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging 32(8):1341-1371. doi:10.1016/j.neurobiolaging.2009.08.007
18. Bartzokis G (2011b) Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front Biosci 16:2695-2733. doi:10.2741/3881
19. Bartzokis G (2012) Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 62(7):2137-2153. doi:10.1016/j.neuropharm.2012.01.015
20. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J (2001) Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58:461-465. doi:10.1001/archpsyc.58.5.461
21. Bartzokis G, Lu PH (2009) Brain volume: age-related changes. In: Squire LR (ed) Encyclopedia of neuroscience, vol 2. Academic Press, Oxford, pp 417-447. doi:10.1016/B978-008045046-9.00107-8
22. Bartzokis G, Lu PH, Geschwind D, Tingus K, Huang D, Mendez MF, Edwards N, Mintz J (2007a) Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry 62(12):1380-1387. doi:10.1016/j.bio-psych. 2007.03.024
23. Bartzokis G, Lu PH, Heydari P, Couvrette A, Lee GJ, Kalashyan G, Freeman F, Grinstead JW, Villablanca P, Finn JP, Mintz J, Alger JR, Altshuler LL (2012) Multimodal MRI assessment of white matter aging trajectories over the lifespan of healthy individuals. Biol Psychiatry 72(12):1026-1034. doi:10.1016/j.biopsych.2012.07.010
24. Bartzokis G, Lu PH, Mintz J (2007b) Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement 3(2):122-125
25. Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J, Neely E, Connor JR (2011) Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 36(7):1375-1384. doi: 10.1038/npp.2011.22
26. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S (2007c) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32(10):1655-1664. doi:10.1007/s11064-007-9352-7
27. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 25(7):843-851. doi:10.1016/j.neurobiolaging.2003.09.005
28. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007d) Brain ferritin iron may influence ageand gender-related risks of neurodegeneration. Neurobiol Aging 28(3):414-423. doi:10.1016/j.neurobiolaging.2006.02.005
29. Bauer J, Bradl M, Klein M, Leisser M, Deckwerth TL, Wekerle H, Lassmann H (2002) Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol 61(1):12-22
30. Behrendt G, Baer K, Buffo A, Curtis MA, Faull RL, Rees MI, Gotz M, Dimou L (2013) Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61(2):273-286
31. Bendlin BB, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Willette AA, Okonkwo OC, Sodhi A, Ries ML, Birdsill AC, Alexander AL, Rowley HA, Puglielli L, Asthana S, Sager MA (2012) CSF T-Tau/Abeta42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One 7(6):e37720
32. Bengtsson SL, Nagy Z, Skare S, Forsman L, Forssberg H, Ullen F (2005) Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 8(9):1148-1150
33. Benigni A, Orisio S, Noris M, Iatropoulos P, Castaldi D, Kamide K, Rakugi H, Arai Y, Todeschini M, Ogliari G, Imai E, Gondo Y, Hirose N, Mari D, Remuzzi G (2012) Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity. Age (Dordr) 35(3): 993-1005
34. Bijur GN, Jope RS (2003) Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 14(18):2415-2419
35. Bild W, Ciobica A (2012) Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala. J Affect Disord 145(2): 165-171
36. Bild W, Hritcu L, Stefanescu C, Ciobica A (2012) Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 43:79-88. doi:10.1016/j.pnpbp.2012.12.009
37. Bishop GM, Dang TN, Dringen R, Robinson SR (2011) Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res 19(3):443-451
38. Bjorkhem I (2006) Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 260(6):493-508
39. Braak E, Braak H (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92:197-201
40. Braak H, Del Tredici K (2012) Alzheimer's disease: pathogenesis and prevention. Alzheimers Dement 8(3):227-233
41. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE (1997) Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension 29(4): 1014-1019
42. Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, Apa Z, Stern Y, Brown TR, Luchsinger JA, Mayeux R (2012) Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol 69(12): 1621-1627
43. Bronge L (2002) Magnetic resonance imaging in dementia. A study of brain white matter changes. Acta Radiol Suppl 428:1-32
44. Bronge L, Bogdanovic N, Wahlund LO (2002) Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 13(4):205-212
45. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ (2012) Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab 32(3):425-436. doi: 10.1038/jcbfm.2011.200
46. Butt AM (2011) ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin Cell Dev Biol 22(2):205-213
47. Butt AM, Berry M (2000) Oligodendrocytes and the control of myelination in vivo: new insights from the rat anterior medullary velum. J Neurosci Res 59(4):477-488
48. Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B (2012) Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res 9(1):5-17
49. Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Grossi P, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P (2009) Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 15(1):36-41
50. Castano EM, Maarouf CL, Wu T, Leal MC, Whiteside CM, Lue LF, Kokjohn TA, Sabbagh MN, Beach TG, Roher AE (2012) Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations. Neurochem Int 62(2):145-156. doi: 10.1016/j.neuint.2012.12.001
51. Castellani RJ, Moreira PI, Perry G, Zhu X (2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. BioFactors 38(2):133-138
52. Chen H, Lukas TJ, Du N, Suyeoka G, Neufeld AH (2009) Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci 50(4):1895-1902
53. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560-2572
54. Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93
55. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O'Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19(16): 3295-3301
56. Costanza A, Xekardaki A, Kovari E, Gold G, Bouras C, Giannakopoulos P (2012) Microvascular burden and Alzheimer-type lesions across the age spectrum. J Alzheimers Dis 32(3):643-652. doi:10.3233/jad-2012-120835
57. Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K (2012) Session III: mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. J Gerontol A Biol Sci Med Sci 67(7):754-759
58. Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100(2):160-178
59. Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM (2011) Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis 26(4):699-708
60. de la Monte SM (1989) Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25(5):450-459
61. de los Monteros AE, Korsak RA, Tran T, Vu D, de Vellis J, Edmond J (2000) Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. Cell Mol Biol (Noisy-le-grand) 46(3):501-515
62. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77(5):461-468
63. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464
64. Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ (2009) Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57(1):54-65
65. Devisser A, Yang C, Herring A, Martinez JA, Rosales-Hernandez A, Poliakov I, Ayer A, Garven A, Zaver S, Rincon N, Xu K, Tuor UI, Schmidt AM, Toth C (2011) Differential impact of diabetes and hypertension in the brain: adverse effects in grey matter. Neurobiol Dis 44(2): 161-173
66. Diamond MC, Rosenzweig MR, Bennett EL, Lindner B, Lyon L (1972) Effects of environmental enrichment and impoverishment on rat cerebral cortex. J Neurobiol 3(1):47-64
67. Dobarro M, Orejana L, Aguirre N, Ramirez MJ (2013) Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model. Neuropharmacology 64:137-144. doi:10.1016/j.neuropharm.2012.06.047
68. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH (2011) Myelin regeneration: a recapitulation of development? Annu Rev Neurosci 34:21-43
69. Fiala JC, Spacek J, Harris KM (2002) Dendritic spine pathology: cause or conséquence of neurological disorders? Brain Res Brain Res Rev 39(1):29-54
70. Fields RD, Burnstock G (2006) Purinergic signalRng in neuron-glia interactions. Nat Rev Neurosci 7(6):423-436
71. Fogarty DJ, Matute C (2001) Angiotensin receptor-like immunoreactivity in adult brain white matter astrocytes and oligodendrocytes. Glia 35(2):131-146
72. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N (2009) Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother 9(9):1413-1431
73. Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9(11):839-855
74. Franklin SS, Wt G, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D (1997) Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96(1):308-315
75. Furiya Y, Ryo M, Kawahara M, Kiriyama T, Morikawa M, Ueno S (2012) Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease. Alzheimers Dement 9(5):512-518
76. Garrido-Gil P, Valenzuela R, Villar-Cheda B, Lanciego JL, Labandeira-Garcia JL (2012) Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra. Brain Struct Funct 218(2):373-388. doi:10.1007/s00429-012-0402-9
77. Geerlings MI, Brickman AM, Schupf N, Devanand DP, Luchsinger JA, Mayeux R, Small SA (2012) Depressive symptoms, antidepressant use, and brain volumes on MRI in a populationbased cohort of old persons without dementia. J Alzheimers Dis 30(1):75-82
78. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 20(3):269-287
79. Gelber RP, Launer LJ, Petrovitch H, Masaki KH, Ross GW, White LR (2013) Beta-blocker treatment of hypertensive older persons decreases the risk of cognitive impairment: the Honolulu-Asia Aging Study. Paper presented at the Presented at the American Academy of Neurology 65th Annual meeting, San Diego, 16-23 March
80. Goldstein IB, Bartzokis G, Guthrie D, Shapiro D (2005) Ambulatory blood pressure and the brain. A 5-year follow-up. Neurology 64(11):1846-1852
81. Gons RA, van Oudheusden LJ, de Laat KF, van Norden AG, van Uden IW, Noms DG, Zwiers MP, van Dijk E, de Leeuw FE (2012) Hypertension is related to the microstructure of the corpus callosum: The RUN DMC study. J Alzheimers Dis 32(3):623-631
82. Grayson DR, Chen Y, Dong E, Kundakovic M, Guidotti A (2009) From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia. Epigenetics 4(3):144-149
83. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2012) TREM2 variants in Alzheimer's disease. N Engl J Med 368(2):117-127
84. Hajjar I, Brown L, Mack WJ, Chui H (2012) Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol 69(12):1632-1637
85. Hajjar I, Hart M, Chen YL, Mack W, Novak V, Chui CH, Lipsitz L (2013) Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial. J Am Geriatr Soc 61(2):194-201. doi:10.1111/jgs. 12100
86. Halder RC, Jahng A, Maricic I, Kumar V (2007) Mini review: immune response to myelin-derived sulfatide and CNS-demyelination. Neurochem Res 32(2):257-262
87. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41-51
88. Han X, Chen M, Wang F, Windrem M, Wang S, Shanz S, Xu Q, Oberheim NA, Bekar L, Betstadt S, Silva AJ, Takano T, Goldman SA, Nedergaard M (2013) Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 12(3):342-353. doi:10.1016/j.stem.2012.12.015
89. Harding JW, Sullivan MJ, Hanesworth JM, Cushing LL, Wright JW (1988) Inability of [125I] Sari, Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments. J Neurochem 50(2):554-557
90. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 10(10):1088-1093
91. Harris JJ, Attwell D (2012) The energetics of CNS white matter. J Neurosci 32(1):356-371
92. Hartman BK, Agrawal HC, Agrawal D, Kalmbach S (1982) Development and maturation of central nervous system myelin: comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc Natl Acad Sci U S A 79(13):4217-4220
93. Hellner K, Walther T, Schubert M, Albrecht D (2005) Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29(3):427-435. doi:10.1016/j.mcn.2005.03.012
94. Hermann K, McDonald W, Unger T, Lang RE, Ganten D (1984) Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. J Physiol (Paris) 79(6): 471-480
95. Hoffman LB, Schmeidler J, Lesser GT, Beeri MS, Purohit DP, Grossman HT, Haroutunian V (2009) Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 72(20):1720-1726
96. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, Englund E, O'Brien JT, Ince PG, Kalaria RN (2010) Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 119(5): 579-589
97. Imabayashi E, Matsuda H, Yoshimaru K, Kuji I, Seto A, Shimano Y, Ito K, Kikuta D, Shimazu T, Araki N (2011) Pilot data on telmisartan short-term effects on glucose metabolism in the olfactory tract in Alzheimer's disease. Brain Behav 1(2):63-69
98. Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M (2009) Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53(2):356-362. doi:10.1161/hypertensionaha. 108.123612
99. Ishizaka N, Saito K, Mori I, Matsuzaki G, Ohno M, Nagai R (2005) Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats. Arterioscler Thromb Vasc Biol 25(11):2282-2288
100. Izawa T, Yamate J, Franklin RJ, Kuwamura M (2010) Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res 1349:105-114
101. Jacobs HI, Leritz EC, Williams VJ, Van Boxtel MP, Elst WV, Jolles J, Verhey FR, McGlinchey RE, Milberg WP, Salat DH (2011) Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health. Hum Brain Mapp 34(1):77-95
102. Jennings JR, Mendelson DN, Muldoon MF, Ryan CM, Gianaros PJ, Raz N, Aizenstein H (2012) Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure. J Hum Hypertens 26(5):295-305. doi:10.1038/jhh.2011.31
103. Jennings JR, Zanstra Y (2009) Is the brain the essential in hypertension? Neuroimage 47(3): 914-921. doi:10.1016/j.neuroimage.2009.04.072
104. Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J (2011) Age-dependent accumulation of soluble amyloid beta (Ajbetaj) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-jalphaj (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3(beta) pathway in Alzheimer mouse model. J Biol Chem 286(21):18414-18425
105. Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, Aparasu RR, Morgan RO (2012) Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement 8(5):437-444. doi:10.1016/j.jalz.2011.05.2414
106. Johnstone D, Milward EA (2010) Genome-wide microarray analysis of brain gene expression in mice on a short-term high iron diet. Neurochem Int 56(6-7):856-863
107. Jonsson T, Stefansson H, Ph DS, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K (2012) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368(2):107-116
108. Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29(2):95-102
109. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 65(5):571-579. doi:10.1038/nn.3357
110. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12(1):138-143
111. Kemper T (1994) Neuroanatomical and neuropathological changes during aging and dementia. In: Albert M, Knoefel J (eds) Clinical neurology of aging, 2nd edn. Oxford University Press, New York, pp 3-67
112. Kennedy KM, Raz N (2009) Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res 1297:41-56
113. Kerr DS, Bevilaqua LR, Bonini JS, Rossato JI, Kohler CA, Medina JH, Izquierdo I, Cammarota M (2005) Angiotensin II blocks memory consolidation through an AT2 receptordependent mechanism. Psychopharmacology (Berl) 179(3):529-535. doi:10.1007/s00213-004-2074-5
114. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD (2006) Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9(2):173-179
115. Kim JK, Samaranayake M, Pradhan S (2008) Epigenetic mechanisms in mammals. Cell Mol Life Sci 66(4):596-612
116. Kimura F, Itami C (2009) Myelination and isochronicity in neural networks. Front Neuroanat 3:12
117. King MR, Anderson NJ, Guernsey LS, Jolivalt CG (2013) Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. J Neurosci Res 91(4):506-514. doi:10.1002/jnr.23192
118. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137(3):149-155
119. Klausberger T, Somogyi P (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321(5885):53-57
120. Knopman DS (2010) Invited commentary: albuminuria and microvascular disease of the braina shared pathophysiology. Am J Epidemiol 171(3):287-289, author reply 290-281
121. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR, Mosley TH Jr (2011) Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 76(22):1879-1885
122. Kolomeets NS, Uranova N (2010) Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study. World J Biol Psychiatry 11(2 Pt 2):282-292
123. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2007) Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 68(12):927-931
124. Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T (2012) Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease. Geriatr Gerontol Int 12(2):207-214
125. Lahiri DK, Sambamurti K, Bennett DA (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 25(5):651-660
126. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger- Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41(10):1094-1099
127. Lassek WD, Gaulin SJ (2012) Sex differences in the relationship of dietary Fatty acids to cognitive measures in american children. Front Evol Neurosci 3:5
128. Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack CR Jr, Toga AW, Weiner MW, Bartzokis G, Thompson PM (2012) Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry 71(9):814-821. doi:10.1016/j.biopsych.2011.12.024
129. Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kolsch H, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Morris CM, Barker R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Combarros O, Arias-Vasquez A, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Oulhaj A, Heun R, Cortina-Borja M, Morgan K, Robson K, Smith AD (2010) Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging 33(1):202e.1-202e.13. doi:10.1016/j.neurobiolaging.2010.07.018
130. Lei P, Ayton S, Bush AI, Adlard PA (2011) GSK-3 in neurodegenerative diseases. Int J Alzheimers Dis 2011:189246
131. Leonard WR, Snodgrass JJ, Robertson ML (2007) Effects of brain evolution on human nutrition and metabolism. Annu Rev Nutr 27:311-327
132. Levine JM, Reynolds R, Fawcett JW (2001) The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24(1):39-47
133. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903-1913
134. Li N-C, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and the risk of dementia in a predominantly male population: a prospective cohort analysis. BMJ (Br Med J) 340:b5465
135. Liu A, Han YR, Li J, Sun D, Ouyang M, Plummer MR, Casaccia-Bonnefil P (2007) The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J Neurosci 27(27):7339-7343
136. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Déficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225(1):54-62
137. Maillard P, Seshadri S, Beiser A, Himali JJ, Au R, Fletcher E, Carmichael O, Wolf PA, Decarli C (2012) Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 11(12):1039-1047
138. Mak IT, Landgraf KM, Chmielinska JJ, Weglicki WB (2012) Angiotensin II promotes iron accumulation and depresses PGI(2) and NO synthesis in endothelial cells: effects of losartan and propranolol analogs. Can J Physiol Pharmacol 90(10):1413-1418
139. Makinodan M, Rosen KM, Ito S, Corfas G (2012) A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337(6100):1357-1360. doi:10.1126/science.1220845
140. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53(4):372-381
141. Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462(2):144-152
142. Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Bjorkhem I, Cedazo-Minguez A (2011) Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. J Alzheimers Dis 24(4):669-679
143. Metzler MJ, Saucier DM, Metz GA (2013) Enriched childhood experiences moderate age-related motor and cognitive decline. Front Behav Neurosci 7:1. doi:10.3389/fnbeh.2013.00001
144. Miller DJ, Duka T, Stimpson CD, Schapiro SJ, Baze WB, McArthur MJ, Fobbs AJ, Sousa AM, Sestan N, Wildman DE, Lipovich L, Kuzawa CW, Hof PR, Sherwood CC (2012) Prolonged myelination in human neocortical evolution. Proc Natl Acad Sci U S A 109(41):16480-16485
145. Mines MA, Beurel E, Jope RS (2011) Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3. Int J Alzheimers Dis 2011:861072
146. Mitew S, Kirkcaldie MT, Halliday GM, Shepherd CE, Vickers JC, Dickson TC (2010) Focal demyelination in Alzheimer's disease and transgenic mouse models. Acta Neuropathol 119(5): 567-577
147. Moghekar A, Kraut M, Elkins W, Troncoso J, Zonderman AB, Resnick SM, O'Brien RJ (2012) Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort. Alzheimers Dement 8(5 Suppl):S71-77. doi:10.1016/j.jalz.2012.04.006
148. Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM (2008) Cortical demyelination in PML and MS: similarities and differences. Neurology 70(5):336-343
149. Morell P, Toews AD (1984) In vivo metabolism of oligodendroglial lipids. In: Norton WT (ed) Oligodendroglia. Plenum, New York, pp 47-86
150. Morton KD, Johnson MD, Van de Kar LD (1995) Serotonin and stress-induced increases in renin secretion are not blocked by sympathectomy/adrenal medullectomy but are blocked by beta antagonists. Brain Res 698(1-2):185-192
151. Munoz MC, Giani JF, Dominici FP (2012) Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul Pept 161(1-3):1-7
152. Murray ME, Vemuri P, Preboske GM, Murphy MC, Schweitzer KJ, Parisi JE, Jack CR Jr, Dickson DW (2012) A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. J Neuropathol Exp Neurol 71(12):1113-1122
153. Nakata T, Takeda K, Hatta T, Kiyama M, Moriguchi J, Miki S, Kawa T, Morimoto S, Nakamura K, Uchida A, Itoh H, Sasaki S, Nakagawa M (1998) Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin. J Cardiovasc Pharmacol 31(2):248-252
154. National Institute of Diabetes and Digestive and Kidney Diseases, (2008) National Diabetes Statistics, 2007 Fact Sheet. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD
155. Nautiyal M, Arnold AC, Chappell MC, Diz DI (2013) The brain renin-angiotensin system and mitochondrial function: influence on blood pressure and baroreflex in transgenic rat strains. Int J Hypertens 2013:136028. doi:10.1155/2013/136028
156. Neumann H, Kotter MR, Franklin RJ (2008) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132(Pt 2):288-295
157. Niu J, Mei F, Li N, Wang H, Li X, Kong J, Xiao L (2010) Haloperidol promotes prolifération but inhibits différentiation in rat oligodendrocyte progenitor cell cultures. Biochem Cell Biol 88(4):611-620
158. Noble M, Arhin A, Gass D, Mayer-Proschel M (2003) The cortical ancestry of oligodendrocytes: common principles and novel features. Dev Neurosci 25(2-4):217-233
159. Norkute A, Hieble A, Braun A, Johann S, Clarner T, Baumgartner W, Beyer C, Kipp M (2009) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 87(6):1343-1355
160. O'Kusky J, Colonnier M (1982) Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: a stereological analysis in normal and monocularly deprived animals. J Comp Neurol 210(3):307-315
161. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68(21):1820-1825
162. Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, Min LJ, Ogimoto A, Dahlof B, Steckelings UM, Unger T, Higaki J, Horiuchi M (2012) Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation. PLoS One 7(11):e48387. doi:10.1371/journal.pone.0048387
163. Ottervald J, Franzen B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellstrom S, Marko- Varga G, Vegvari A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T (2013) Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. J Proteomics 73(6):1117-1132
164. Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B (2007) Neocortical glial cell numbers in human brains. Neurobiol Aging 29(11):1754-1762
165. Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, Rakic P, Kostovic I (2012) Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci U S A 108(32): 13281-13286
166. Peters A (2007) The effects of normal aging on nerve fibers and neuroglia in the central nervous system. In: Riddle DR (ed) Brain aging: models, methods, and mechanisms. Frontiers in neuroscience. CRC, Boca Raton, FL
167. Peters A (2009) The effects of normal aging on myelinated nerve fibers in monkey central nervous system. Front Neuroanat 3 (article 11): 10 p
168. Peters A, Kemper T (2012) A review of the structural alterations in the cerebral hemispheres of the aging rhesus monkey. Neurobiol Aging 33(10):2357-2372
169. Peters A, Sethares C (2003) Is there remyelination during aging of the primate central nervous system? J Comp Neurol 460(2):238-254
170. Peters A, Sethares C (2004) Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb Cortex 14:995-1007
171. Peters A, Sethares C, Moss MB (2010) How the primate fornix is affected by age. J Comp Neurol 518(19):3962-3980
172. Peters A, Verderosa A, Sethares C (2008) The neuroglial population in the primary visual cortex of the aging rhesus monkey. Glia 56(11):1151-1161
173. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging 21(1):57-62
174. Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, Hennerici M, Scheltens P, Erkinjuntti T, Visser M, Langhorne P, Chabriat H, Waldemar G, Wallin A, Wahlund A (2011) 2001-2011: A decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32(6):577-588. doi:10.1159/000334498
175. Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJ, Rudin M, Suter U (2011) Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 31(3):1069-1080
176. Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinisto L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN (2010) Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology 75(23):2071-2078
177. Popkie AP, Zeidner LC, Albrecht AM, D'Ippolito A, Eckardt S, Newsom DE, Groden J, Doble BW, Aronow B, McLaughlin KJ, White P, Phiel CJ (2010) Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J Biol Chem 285(53):41337-41347
178. Popko B (2008) Epigenetic control of myelin repair. Nat Neurosci 11(9):987-988
179. Power J, Mayer-Proschel M, Smith J, Noble M (2002) Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Dev Biol 245(2):362-375
180. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM (2004) Cerebral white matter lesions and the risk of dementia. Arch Neurol 61(10): 1531-1534. doi:10.1001/archneur.61.10.1531
181. Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patino C (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153(1):42-54
182. Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25(5):641-650
183. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Longstreth WT Jr, Gach HM, Boardman J, Bernick CB, Thompson PM, Becker JT (2012) White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 33(4):834e837-834e816
184. Rakic P (2002) Genesis of neocortex in human and nonhuman primates. In: Lewis M (ed) Child and adolescent psychiatry: a comprehensive textbook, 3rd edn. Lippincott Williams & Williams, Philadelphia, PA, pp 22-46
185. Ranadive SA, Chen AX, Serajuddin AT (1992) Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors. Pharm Res 9(11): 1480-1486
186. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D (2011) Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 31(2):538-548
187. Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, Geurts JJ (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 15(6): 708-714
188. Saavedra JM (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) 123(10):567-590
189. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA (2005) High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8(4):468-475
190. Sakai T, Mikami A, Tomonaga M, Matsui M, Suzuki J, Hamada Y, Tanaka M, Miyabe-Nishiwaki T, Makishima H, Nakatsukasa M, Matsuzawa T (2011) Differential prefrontal white matter development in chimpanzees and humans. Curr Biol 21(16):1397-1402
191. Salami M, Itami C, Tsumoto T, Kimura F (2003) Change of conduction velocity by regional myelination yields constant latency irrespective of distance between thalamus and cortex. Proc Natl Acad Sci U S A 100(10):6174-6179
192. Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD (2010) White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 31(2):244-256
193. Salat DH, Williams VJ, Leritz EC, Schnyer DM, Rudolph JL, Lipsitz LA, McGlinchey RE, Milberg WP (2012) Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults. Neuroimage 59(1):181-192
194. Sanchez-Abarca LI, Tabernero A, Medina JM (2001) Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 36(3):321-329
195. Schoenemann PT, Sheehan MJ, Glotzer LD (2005) Prefrontal white matter volume is disproportionately larger in humans than in other primates. Nat Neurosci 8(2):242-252
196. Scholz J, Klein MC, Behrens TE, Johansen-Berg H (2009) Training induces changes in whitematter architecture. Nat Neurosci 12(11):1370-1371
197. Schonberg DL, Goldstein EZ, Sahinkaya FR, Wei P, Popovich PG, McTigue DM (2012) Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 32(16):5374-5384
198. Schonberg DL, McTigue DM (2009) Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol 218(1):64-74
199. Schuitemaker A, van der Doef TF, Boellaard R, van der Flier WM, Yaqub M, Windhorst AD, Barkhof F, Jonker C, Kloet RW, Lammertsma AA, Scheltens P, van Berckel BN (2012) Microglial activation in healthy aging. Neurobiol Aging 33(6):1067-1072
200. Schulz K, Kroner A, David S (2012) Iron efflux from astrocytes plays a role in remyelination. J Neurosci 32(14):4841-4847. doi:10.1523/jneurosci.5328-11.2012
201. Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31(37):13301-13311. doi:10.1523/jneurosci.2838-11.2011
202. Scotland PB, Heath JL, Conway AE, Porter NB, Armstrong MB, Walker JA, Klebig ML, Lavau CP, Wechsler DS (2012) The PICALM protein plays a key role in iron homeostasis and cell proliferation. PLoS One 7(8):e44252
203. Shen S, Liu A, Li J, Wolubah C, Casaccia-Bonnefil P (2006) Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol Aging 29(3):452-463
204. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia-Bonnefil P (2008) Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11(9):1024-1034
205. Shields SA, Gilson JM, Blakemore WF, Franklin RJ (1999) Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28(1):77-83
206. Shih AY, Blinder P, Tsai PS, Friedman B, Stanley G, Lyden PD, Kleinfeld D (2013) The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci 16(1):55-63. doi:10.1038/nn.3278
207. Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA (2012) Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 79(8):741-747. doi:10.1212/WNL.0b013e3182661f2b
208. Simon B, Schmidt S, Lukas C, Gieseke J, Traber F, Knol DL, Willinek WA, Geurts JJ, Schild HH, Barkhof F, Wattjes MP (2010) Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 20(7): 1675-1683
209. Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr (2009) Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med 169(13):1195-1202
210. Sinka L, Kovari E, Gold G, Hof PR, Herrmann FR, Bouras C, Giannakopoulos P (2010) Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old. J Neuropathol Exp Neurol 69(12):1247-1255. doi:10.1097/NEN.0b013e3181ffc3b9
211. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172(4):1053-1061
212. Smaers JB, Schleicher A, Zilles K, Vinicius L (2010) Frontal white matter volume is associated with brain enlargement and higher structural connectivity in anthropoid primates. PLoS One 5(2):e9123
213. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM (2012) Cerebral microinfarcts: the invisible lesions. Lancet Neurol 11(3):272-282. doi:10.1016/s1474-4422(11)70307-6
214. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62(4):406-413. doi:10.1002/ana.21208
215. Soros P, Whitehead S, Spence JD, Hachinski V (2012) Antihypertensive treatment can prevent stroke and cognitive decline. Nat Rev Neurol 9(3):174-178. doi:10.1038/nrneurol.2012.255
216. Sow A, Lamant M, Bonny JM, Larvaron P, Piaud O, Lecureuil C, Fontaine I, Saleh MC, Garcia Otin AL, Renou JP, Baron B, Zakin M, Guillou F (2006) Oligodendrocyte differentiation is increased in transferrin transgenic mice. J Neurosci Res 83(3):403-414
217. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B (2004) Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161(5):882-888
218. Staschewski J, Kulisch C, Albrecht D (2012) Different isoforms of nitric oxide synthase are involved in angiotensin-(1-7)-mediated plasticity changes in the amygdala in a genderdependent manner. Neuroendocrinology 94(3):191-199
219. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7(1):63-80
220. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B (2008) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42(2):151-157
221. Stornetta RL, Hawelu-Johnson CL, Guyenet PG, Lynch KR (1988) Astrocytes synthesize angio-tensinogen in brain. Science 242(4884):1444-1446
222. Sutherland C (2011) What are the bona fide GSK3 Substrates? Int J Alzheimers Dis 2011:505-607
223. Syner FN, Goodman M (1966) Differences in the lactic dehydrogenases of primate brains. Nature 209(5021):426-428
224. Szeligo F, Leblond CP (1977) Response of the three main types of glial cells of cortex and corpus callosum in rats handled during suckling or exposed to enriched, control and impoverished environments following weaning. J Comp Neurol 172(2):247-263
225. Takao M, Koto A, Tanahashi N, Fukuuchi Y, Takagi M, Morinaga S (1999) Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci 167:127-131
226. Tanzi RE (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2(10), doi:10.1101/cshperspect.a006296
227. Terman A, Brunk UT (2004) Lipofuscin. Int J Biochem Cell Biol 36(8):1400-1404. doi:10.1016/j.biocel.2003.08.009
228. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. AnnNeurol 30:572-580
229. Thompson MM, Oyama TT, Kelly FJ, Kennefick TM, Anderson S (2000) Activity and responsiveness of the renin-angiotensin system in the aging rat. Am J Physiol Regul Integr Comp Physiol 279(5):R1787-1794
230. Tian J, Shi J, Bailey K, Harris JM, Pritchard A, Lambert JC, Chartier-Harlin MC, Pickering-Brown SM, Lendon CL, Mann DM (2004) A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease. Neurosci Lett 354(2):103-106
231. Tian M, Zhu D, Xie W, Shi J (2012) Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. FEBS Lett 586(20):3737-3745
232. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57(5):467-478
233. Tripathi RB, Clarke LE, Burzomato V, Kessaris N, Anderson PN, Attwell D, Richardson WD (2011) Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts. J Neurosci 31(18):6809-6819
234. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE 4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70(2):223-228. doi:10.1001/jamaneurol.2013.600
235. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67(2-3):269-275
236. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39(10):2712-2719. doi:10.1161/strokeaha.107.513176
237. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. Jama 287(8):1003-1010
238. Versace A, Andreazza AC, Young LT, Fournier JC, Almeida JR, Stiffler RS, Lockovich JC, Aslam HA, Pollock MH, Park H, Nimgaonkar VL, Kupfer DJ, Phillips ML (2013) Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry. doi:10.1038/mp.2012.188
239. Vinet J, Lemieux P, Tamburri A, Tiesinga P, Scafidi J, Gallo V, Sik A (2010) Subclasses of oligodendrocytes populate the mouse hippocampus. Eur J Neurosci 31(3):425-438
240. Voineskos AN, Foussias G, Lerch J, Felsky D, Remington G, Rajji TK, Lobaugh N, Pollock BG, Mulsant BH (2013) Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry 70(5):472-480. doi:10.1001/jamapsychiatry.2013.786
241. Vostrikov V, Uranova N (2011) Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treat (Article ID 174689P:10 pages. doi:10.1155/2011/174689
242. Vostrikov VM, Uranova NA, Orlovskaya DD (2007) Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 94(1-3):273-280
243. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67(6):960-967
244. White LR, Gelber RP, Launer LJ, Zarow C, Sonnen J, Uyehara-Lock J, Masaki K, Ross GW, Petrovitch H (2013) Beta blocker treatment of hypertensive older persons ameliorates the brain lesions of dementia measured at autopsy: the Honolulu-Asia Aging Study. Paper presented at the Presented at the American Academy of Neurology 65th Annual meeting, San Diego, 16-23 March
245. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71(14): 1057-1064
246. Wiggins RC (1982) Myelin development and nutritional insufficiency. Brain Res 257(2):151-175
247. Wishart TM, Parson SH, Gillingwater TH (2006) Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol 65(8):733-739
248. Xia H, Suda S, Bindom S, Feng Y, Gurley SB, Seth D, Navar LG, Lazartigues E (2012) ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One 6(7):e22682
249. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69(9)11170-1175
250. Yang S, Li C, Qiu X, Zhang L, Lu W, Chen L, Zhao YY, Shi XY, Huang CX, Cheng GH, Tang Y (2013) Effects of an enriched environment on myelin sheaths in the white matter of rats during normal aging: a stereological study. Neuroscience 234C:13-21. doi: 10.1016/j.neuroscience.2013.01.003
251. Yang Y, Faustino PJ, Volpe DA, Ellison CD, Lyon RC, Yu LX (2007) Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership. Mol Pharm 4(4): 608-614. doi:10.1021/mp070028i
252. Yuskaitis CJ, Jope RS (2009) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21(2):264-273
253. Zajc Petranovic M, Skaric-Juric T, Smolej Narancic N, Tomas Z, Krajacic P, Milicic J, Barbalic M, Tomek-Roksandic S (2012) Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans. Age (Dordr) 34(3):583-595
254. Zhang K, Sejnowski TJ (2000) A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci U S A 97(10):5621-5626
255. Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T (2010) Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171(3):852-858
256. Zhao WQ, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim Biophys Acta 1792(5): 482-496
257. Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, Brodaty H, Wen W (2012) Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 79(8):748-754. doi:10.1212/WNL.0b013e3182661f4d
258. Zimmerman MC (2011) Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Curr Opin Pharmacol 11(2):138-143
259. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE (2007) Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10(3):321-330